First Time Loading...

Shinpoong Pharmaceutical Co Ltd
KRX:019170

Watchlist Manager
Shinpoong Pharmaceutical Co Ltd Logo
Shinpoong Pharmaceutical Co Ltd
KRX:019170
Watchlist
Price: 14 230 KRW -2.13%
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shinpoong Pharmaceutical Co Ltd

Wall Street analysts forecast Shinpoong Pharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shinpoong Pharmaceutical Co Ltd is 5 769 KRW .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
5 769 KRW
59% Downside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
5 769 KRW
59% Downside
Highest
Price Target
Not Available
Shinpoong Pharmaceutical Co Ltd Competitors:
Price Targets
600216
Zhejiang Medicine Co Ltd
40% Upside
4887
Sawai Group Holdings Co Ltd
13% Upside
T
600867
Tonghua Dongbao Pharmaceutical Co Ltd
42% Upside
688513
Chengdu Easton Biopharmaceuticals Co Ltd
4% Upside
600216
Zhejiang Medicine Co Ltd
40% Upside
4887
Sawai Group Holdings Co Ltd
13% Upside
T
600867
Tonghua Dongbao Pharmaceutical Co Ltd
42% Upside
688513
Chengdu Easton Biopharmaceuticals Co Ltd
4% Upside
950
Lee's Pharmaceutical Holdings Ltd
14% Downside
VENUSREM
Venus Remedies Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Shinpoong Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Shinpoong Pharmaceutical Co Ltd's revenue is 0%.

0%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shinpoong Pharmaceutical Co Ltd

Operating Income forecast
is not available for
Shinpoong Pharmaceutical Co Ltd

Net Income
Forecast

Net Income Estimate
Shinpoong Pharmaceutical Co Ltd

Net Income forecast
is not available for
Shinpoong Pharmaceutical Co Ltd

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shinpoong Pharmaceutical Co Ltd's stock price target?
Price Target
5 769 KRW

According to Wall Street analysts, the average 1-year price target for Shinpoong Pharmaceutical Co Ltd is 5 769 KRW .

ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.